Source: Annual Congress 2006 - From genes to outcome: a long distance
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Tesse, F. Cardinale, A. Dellino, T. Tronci, F. Di Domenico, F. Cristofori, O. Sillecchia, F. De Robertis, A. Manca, L. Armenio (Bari, Italy). Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis. Eur Respir J 2006; 28: Suppl. 50, 4118

Member's Comments

No comment yet.

Related content which might interest you: Interleukin-6 gene variants are associated with early Pseudomonas infection in cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 727s Year: 2005 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Interleukin-1 receptor antagonist gene polymorphism and Pseudomonas aeruginosa chronic infection in children with cystic fibrosis Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies Year: 2003 Single nucleotide polymorphisms in genes of the innate immunity in cystic fibrosis patients: correlation with lung function and pseudomonas aeruginosa (P.a.) colonisation Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease Source: Eur Respir J 2014; 44: 1608-1615 Year: 2014 Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis Source: Eur Respir J 2007; 30: 286-292 Year: 2007 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Eradication of Pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2006; 27: 653 Year: 2006 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Azithromycin in chronic respiratory infections with pseudomonas aeruginosa in patients without cystic fibrosis Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Association of IL-8 A-251T polymorphism with Pseudomonas aeruginosa infection and lung function decline in children with CF Source: Eur Respir J 2005; 26: Suppl. 49, 726s Year: 2005 Pseudomonas aeruginosa infections Source: Respipedia Article Year: 2018 Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis? Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003 Highly concentrated aerosolized tobramycin in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015